Phase IV randomized, single-blind clinical trial with three parallel arms to compare ovulation triggering strategies in IVF cycles with fresh embryo transfer.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-526292-37-01

Enrollment

126

Registered

2026-07-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women with infertility and low ovarian reserve.

Brief summary

Number of metaphase II (MII) oocytes retrieved at oocyte pickup.

Detailed description

Proportion of mature oocytes (MII/total oocytes)., Biochemical pregnancy rate and ongoing pregnancy rate., Gene expression of receptors and enzymes involved in folliculogenesis and ovarian steroidogenesis in mature oocytes.

Interventions

DRUGOrgalutran 0.25 mg/0.5 mL solution for injection

DRUGDecapeptyl diario 0

DRUG1 mg polvo y disolvente para solución inyectable

DRUGREKOVELLE 72 micrograms/2.16 mL solution for injection in a pre-filled pen

DRUGREKOVELLE 36 micrograms/1.08 mL solution for injection in a pre-filled pen

DRUGOvitrelle 250 micrograms solution for injection in pre-filled pen

DRUGMeriofert Kit 900 UI polvo y disolvente para solución inyectable

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Number of metaphase II (MII) oocytes retrieved at oocyte pickup.	—

Secondary

Measure	Time frame
Proportion of mature oocytes (MII/total oocytes)., Biochemical pregnancy rate and ongoing pregnancy rate., Gene expression of receptors and enzymes involved in folliculogenesis and ovarian steroidogenesis in mature oocytes.	—

Outcome results

None listed

Source: EU CTIS · Data processed: Jul 15, 2026